This is the logo of the provider
5 June 2026

Cardiometabolic Outcomes in Adults With Type 2 Diabetes Treated With 1 mg Semaglutide Who Titrate to 2 mg Semaglutide vs Switch to Tirzepatide

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Diabetes
Congress poster
GLP-1 RA
Semaglutide
RWE HEOR